Skip to main content

Table 1 Baseline characteristics of patients in two groups divided by GNRI

From: Relationship between mortality and Geriatric Nutritional Risk Index (GNRI) at the time of dialysis initiation: a prospective multicenter cohort study

Parameter

High group (n = 728)

Low group (n = 761)

P value

Male (%)

69.4

66.0

0.1607

Age (years)

65.8 ± 13.2

69.1 ± 12.8

<0.001

Height (cm)

160.1 ± 9.2

158.8 ± 9.7

0.0059

Body weight (kg)

62.0 ± 13.1

58.2 ± 14.1

<0.001

BMI (kg/cm2)

24.0 ± 4.0

22.9 ± 4.5

<0.001

GNRI

95.2 ± 4.9

80.3 ± 6.1

<0.001

UFV (L)

0.801 ± 0.827

0.967 ± 0.919

<0.001

ACEi or ARB (%)

64.0

57.4

0.0093

β blocker (%)

36.7

33.2

0.1652

Statin (%)

39.7

40.5

0.7603

VDRA (%)

32.6

22.9

<0.001

ESA (%)

88.9

84.1

0.0072

Diabetes (%)

44.5

57.6

<0.001

History of CAD (%)

14.7

18.8

0.0347

History of PCI (%)

9.5

10.9

0.3627

History of CABG (%)

3.7

4.6

0.3899

History of HF Ad (%)

16.6

24.3

0.0002

History of CI (%)

12.6

14.6

0.2733

History of ICH (%)

3.2

2.6

0.5406

History of AD (%)

5.1

6.0

0.4185

History of PAD, F2 (%)

3.6

5.7

0.0564

Amputation (%)

1.0

2.1

0.0743

CVD (%)

40.1

49.5

0.0003

Comorbid MI (%)

4.0

7.2

0.0067

Comorbid HF (%)

18.3

31.5

<0.001

Comorbid PAD (%)

3.7

6.4

0.0167

Comorbid stroke (%)

7.4

10.1

0.0659

SBP (mmHg)

152.5 ± 25.4

150.1 ± 26.4

0.0694

CTR (%)

54.1 ± 7.2

56.2 ± 6.9

<0.001

WBC (1000/μL)

6.3 ± 2.9

7.1 ± 3.3

<0.001

Hb (g/dL)

9.77 ± 1.45

9.00 ± 1.54

<0.001

Plt (10000/μL)

17.3 ± 7.2

19.0 ± 7.9

<0.001

ALB (g/dL)

3.67 ± 0.34

2.75 ± 0.41

<0.001

eGFR (ml/min/1.7m2)

5.21 ± 1.84

5.67 ± 2.52

<0.001

Na (mEq/L)

138.2 ± 4.0

137.6 ± 4.7

0.0045

K (mEq/L)

4.61 ± 0.77

4.48 ± 0.838

0.0020

cCa (mg/dL)

8.44 ± 1.05

8.78 ± 1.03

<0.001

P (mg/dL)

6.23 ± 1.61

6.48 ± 2.10

0.0095

Mg (mg/dL)

2.20 ± 0.50

2.10 ± 0.44

<0.001

UA (mg/dL)

8.71 ± 2.33

8.82 ± 2.45

0.3660

LDL-C (mg/dL)

87.5 ± 31.9

92.0 ± 36.6

0.0168

CRP (mg/dL)

0.88 ± 2.48

2.68 ± 5.10

<0.001

TSAT (%)

28.4 ± 16.3

25.9 ± 16.9

0.0130

Ferritin (ng/mL)

221.6 ± 1328.5

220.5 ± 506.0

0.9846

LVEF (%)

60.8 ± 12.5

60.6 ± 12.0

0.7771

All-cause death (%)

12.6

22.2

<0.001

Infection death (%)

1.9

5.5

0.0003

CVD death (%)

5.2

7.6

0.0593

Malignancy death (%)

3.0

3.0

0.9998

  1. GNRI Geriatric Nutritional Risk Index, UFV ultrafiltlation volume, BMI body mass index, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, VDRA vitamin D receptor agonist, ESA erythropoietin stimulating agent, CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, HF heart failure, Ad admission, CI cerebral infarction, ICH intracerebral hemorrhage, AD aortic disease, PAD, F2 peripheral arterial disease with Fontaine classification 2-4, CVD cardiovascular disease, MI myocardial infarction, SBP systolic blood pressure, CTR cardiothoracic ratio, WBC white blood cells, Hb hemoglobin, Plt platelet, ALB albumin, eGFR estimated glomerular filtration rate, Na sodium, K potassium, cCa corrected calcium, P phosphate, Mg magnesium, UA uric acid, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, TSAT transferrin saturation, LVEF left ventricular ejection fraction, CVD cardiovascular disease